You are here

Prescription: Washington

New FDA Commissioner to Face Vital Drug Safety Concerns: Companies Slow to Complete Postmarketing Trials

Stephen Barlas
PDF version: 
Stephen Barlas emphasizes the need for drug manufacturers to complete promised postmarketing (phase 4) trials in a timely way—this is just one of many challenges facing the new FDA Commissioner.